Final Programme

Scientific Programme Sunday, April 2, 2006
O133 Clinical and microbiological data of
14:36 patients infected with multidrug-resistant
Mycobacterium tuberculosis strains
carrying gyrase mutations
N. Veziris, J. Robert, C. Truffot-Pernot, V. Jarlier,
E. Cambau, A. Aubry (Paris, Créteil, FR)
O134 Implementation of automated mycobacterial
14:48 interspersed repetitive unit – variable number
of tandem repeat (MIRU-VNTR) typing in a
routine laboratory setting
C. Allix, P. Supply, M. Fauville-Dufaux
(Brussels, BE; Lille, FR)
Symposia
Apollon Current aspects on MRSA
15:30–
17:30 Chairpersons: Jerôme Etienne (Lyon, FR)
Gary L. French (London, UK)
S135 Current status of rapid detection
15:30 Jacques Schrenzel (Geneva, CH)
S136 The current situation of community-acquired
16:00 MRSA in Europe
Jerôme Etienne (Lyon, FR)
S137 MRSA transmission dynamics in hospitals:
16:30 will control policies finally succeed?
Ben Cooper (London, UK)
S138 Role of new therapeutics
17:00 Harald Labischinski (Wurzburg, DE)
Méditerranée 2 Mechanisms of infectious diseases:
15:30– new science and novel insights
17:30 Chairpersons: Philippe Sansonetti (Paris, FR)
Christoph M. Tang (London, UK)
S139 Neisseria meningitidis: new genes that
15:30 effect invasion
Christoph M. Tang (London, UK)
S140 Cell biology and shigellosis
16:00 Philippe Sansonetti (Paris, FR)
S141 Innate immunity and Streptococcus
16:30 pneumoniae
Robert Read (Sheffield, UK)
S142 Brucellosis: novel virulence determinants
17:00 and cellular organelles
Jean-Pierre Gorvel (Marseille, FR)
Joint symposium arranged with the Federation of
European Microbiolobical Societies (FEMS)
Hermes Foreign body infections
15:30–
17:30 Chairpersons: Mathias Herrmann (Homburg, DE)
Jean-Paul Stahl (Grenoble, FR)
S143 Staphylococci – versatile microorganisms
15:30 adapted to the foreign surface
Mathias Herrmann (Homburg, DE)
S144 Breast implant infection in aesthetic
16:00 and reconstructive surgery
Brigitte Pittet (Geneva, CH)
S145 Orthopaedic infections: tricky to diagnose,
16:30 hard to treat
Andrej Trampuz (Basel, CH)
S146 Piercing, tattooing and other body
17:00 modifications
Jean-Baptiste Guiard-Schmid (Paris, FR)
Oral Sessions
Méditerranée 3 Antimicrobial clinical trials
15:30–
17:30 Chairpersons: Roman Kozlov (Smolensk, RU)
David Denning (Manchester, UK)
O147 Skin disinfection with octenidine dihydro-
15:30 chloride for central venous catheter placement
and care – a randomised controlled trial
M. Dettenkofer, C. Wilson, A. Gratwohl,
D. Bolliger, C. Schmoor, D. Heim, H. Bertz,
D. Luft, S. Schulz, F.D. Daschner,
A.F. Widmer (Freiburg, DE; Basel, CH)
O148 Pooled analysis of the mortality and cardiac
15:42 safety of moxifloxacin
S. Choudhri, F. Krüsmann, C. Reiter
(West Haven, US; Wuppertal, DE)
O149 Short-course fluoroquinolones vs. single dose
15:54 fosfomycin for acute uncomplicated cystitis:
systematic review and meta-analysis
V. Rafalskiy, T. Perepanova, V. Bistryukov
(Smolensk, Moscow, RU)
O150 A clinical and laboratory evaluation of
16:06 PAR-101 in patients with Clostridium
difficile-associated diarrhoea
T.J. Louie, M. Miller, C. Donskey, K. Mullane,
E.J.C. Goldstein, D.M. Citron, M. Corrado,
S.L. Gorbach, P. Sears, S. Shangle, B. Walsh,
Y.-K. Shue (Calgary, Montreal, CA; Cleveland,
Chicago, Santa Monica, New Hope, San Diego, US)
www.escmid.org/eccmid2006 page 43